3 Mar 2006 11:07
Cambridge Antibody Tech Group PLC03 March 2006 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company Cambridge Antibody Technology Group plc 2. Name of shareholder having a major interest OrbiMed 3. Please state whether notification indicates that it is in respect of holdingof the shareholder named in 2 above or in respect of a non-beneficial interestor in the case of an individual holder if it is a holding of that person'sspouse or children under the age of 18 As in 2. above 4. Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them Not known 5. Number of shares / amount of stock acquired N/A 6. Percentage of issued class N/A 7. Number of shares / amount of stock disposed Not known 8. Percentage of issued class Not Known 9. Class of security Ordinary 10 pence Shares 10. Date of transaction Not known 11. Date company informed 3 March 2006 12. Total holding following this notification Not known 13. Total percentage holding of issued class following this notification Not known 14. Any additional information The Company has been advised that Orbimed Advisors LLC and OrbiMed Capital LLC(collectively "Orbimed" ), through various entities over which it hasinvestment discretion, no longer has any interest in ordinary shares or ADR's ofthe Company 15. Name of contact and telephone number for queries Justin Hoskins, 01223 898589 16. Name and signature of authorised company official responsible for makingthis notification Justin Hoskins, Company Secretary Date of notification 3 March 2006 The FSA does not give any express or implied warranty as to the accuracy of thisdocument or material and does not accept any liability for error or omission.The FSA is not liable for any damages (including, without limitation, damagesfor loss of business or loss of profits) arising in contract, tort or otherwisefrom the use of or inability to use this document, or any material contained init, or from any action or decision taken as a result of using this document orany such material. This information is provided by RNS The company news service from the London Stock Exchange